[From phase I-IV-Correctly understand and assess study designs in ophthalmology]

Kristina Pfau1,2, Anja Deutsch3, Robert Németh4

  • 1Universitäts-Augenklinik Bonn, Universitätsklinikum Bonn, Bonn, Deutschland. Kristina.Pfau@ukbonn.de.

Die Ophthalmologie
|July 20, 2026
PubMed
Summary

Evaluating new ophthalmology treatments requires understanding clinical trial phases (I-IV). This guide helps clinicians critically assess evidence, focusing on study design and potential biases for better treatment decisions.